C.R.S. Section 25-45-106
Access to investigational drugs, biological products, and devices

25–45–101
Short title 25–45–102
Legislative declaration 25–45–103
Definitions 25–45–104
Drug manufacturers - availability of investigational drugs, biological products, or devices - costs - insurance coverage 25–45–105
Action against health-care provider’s license or medicare certification prohibited 25–45–106
Access to investigational drugs, biological products, and devices 25–45–107
No cause of action created 25–45–108
Effect on health-care coverage